0001562180-22-008148.txt : 20221208
0001562180-22-008148.hdr.sgml : 20221208
20221208083804
ACCESSION NUMBER: 0001562180-22-008148
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221205
FILED AS OF DATE: 20221208
DATE AS OF CHANGE: 20221208
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Green Eric Mark
CENTRAL INDEX KEY: 0001336007
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-08036
FILM NUMBER: 221451483
MAIL ADDRESS:
STREET 1: 530 HERMAN O. WEST DRIVE
CITY: EXTON
STATE: PA
ZIP: 19341
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: WEST PHARMACEUTICAL SERVICES INC
CENTRAL INDEX KEY: 0000105770
STANDARD INDUSTRIAL CLASSIFICATION: FABRICATED RUBBER PRODUCTS, NEC [3060]
IRS NUMBER: 231210010
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 530 HERMAN O. WEST DRIVE
CITY: EXTON
STATE: PA
ZIP: 19341
BUSINESS PHONE: 6105942900
MAIL ADDRESS:
STREET 1: 530 HERMAN O. WEST DRIVE
CITY: EXTON
STATE: PA
ZIP: 19341
FORMER COMPANY:
FORMER CONFORMED NAME: WEST CO INC
DATE OF NAME CHANGE: 19990405
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2022-12-05
false
0000105770
WEST PHARMACEUTICAL SERVICES INC
WST
0001336007
Green Eric Mark
530 HERMAN O. WEST DRIVE
EXTON
PA
19341
true
true
false
false
President & CEO
Common Stock
2022-12-05
4
M
false
50000.00
57.38
A
158922.0865
D
Common Stock
2022-12-05
4
S
false
6746.00
236.9488
D
152176.0865
D
Common Stock
2022-12-05
4
S
false
9408.00
237.6676
D
142768.0865
D
Common Stock
2022-12-05
4
S
false
6312.00
238.8268
D
136456.0865
D
Common Stock
2022-12-05
4
S
false
10752.00
239.6972
D
125704.0865
D
Common Stock
2022-12-05
4
S
false
9682.00
240.7328
D
116022.0865
D
Common Stock
2022-12-05
4
S
false
1100.00
241.4645
D
114922.0865
D
Stock Option (Right to Buy)
57.38
2022-12-05
4
M
false
50000.00
0.00
D
2025-04-24
Common Stock
50000.00
248132.00
D
The shares reported were acquired by the Reporting Person from exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was completed pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on 9/14/2022.
This transaction was effective pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on 9/14/2022. The Rule 10b5-1 trading plan, which was structured to include several sale periods, was established as part of the Reporting Person's long-term strategy for asset diversification and financial, retirement, estate and tax planning activities over a period of time.
The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $236.255 to $237.245, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $237.255 to $238.21, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $238.26 to $239.25, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $239.26 to $240.25, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $240.29 to $241.27, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $241.33 to $241.56, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
This option is fully vested.
Ryan Metz as Agent for Eric M. Green
2022-12-06